Equillium, Inc. Contracts & Agreements
54 Contracts & Agreements
- Business Finance (17 contracts)
- Business Operations (8)
- Human Resources (10)
- Mergers & Acquisitions (2)
- Real Estate (1)
- Uncategorized (16)
- Equillium, Inc. 2024 Inducement Plan and Forms of Stock Option Grant Notice, Option Agreement, and Notice of Exercise thereunder (Filed With SEC on May 9, 2024)
- Open Market Sale Agreement, dated as of October 5, 2023, by and between Equillium, Inc. and Jefferies LLC (Filed With SEC on October 5, 2023)
- Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Filed With SEC on August 9, 2023)
- Clinical Supply Agreement, dated May 22, 2017, by and between Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Filed With SEC on August 9, 2023)
- Agreement and Plan of Merger, dated September 6, 2022, by and among Equillium, Inc., Metacrine, Inc., Equillium Acquisition Sub, Inc., and Triumph Merger Sub, Inc (Filed With SEC on September 6, 2022)
- First Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated December 18, 2020 (Filed With SEC on March 23, 2022)
- Amended and Restated Equillium, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 23, 2022)
- Third Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated February 14, 2022 (Filed With SEC on March 23, 2022)
- Confidential Separation Agreement and General Release of All Claims dated February 13, 2022, by and between Registrant and Dolca Thomas, M.D (Filed With SEC on March 23, 2022)
- Agreement and Plan of Merger, dated February 14, 2022, by and among the Company, Bioniz, Merger Sub and Kevin Green, solely in his capacity as Securityholders Representative (Filed With SEC on February 16, 2022)
- Fourth Amendment to Collaboration and License Agreement by and between Registrant and Biocon Limited, dated April 14, 2021 (Filed With SEC on May 13, 2021)
- Second Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated April 23, 2021 (Filed With SEC on May 13, 2021)
- Amended and Restated Offer Letter, effective January 26, 2021, by and between the Registrant and Joel Rothman (Filed With SEC on March 24, 2021)
- Equillium, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 24, 2021)
- Form of Warrant (Filed With SEC on February 4, 2021)
- Purchase Agreement between the Company and the Purchasers, dated February 3, 2021 (Filed With SEC on February 4, 2021)
- Offer Letter, dated December 15, 2020, by and between Equillium, Inc. and Dolca Thomas, M.D (Filed With SEC on December 21, 2020)
- Second Amendment to Offer Letter, effective as of September 28, 2020, by and between the Company and Krishna Polu (Filed With SEC on September 28, 2020)
- Underwriting Agreement, dated August 13, 2020, by and among Equillium, Inc. and Jefferies LLC, SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated, acting as the... (Filed With SEC on August 14, 2020)
- Equillium, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 12, 2020)
- Open Market Sale Agreement, dated as of July 14, 2020, by and between Equillium, Inc. and Jefferies LLC (Filed With SEC on July 14, 2020)
- Registration Rights Agreement, dated as of March 27, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC (Filed With SEC on March 30, 2020)
- Purchase Agreement, dated as of March 27, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC (Filed With SEC on March 30, 2020)
- Description of Common Stock (Filed With SEC on March 26, 2020)
- Second Amendment to Collaboration and License Agreement, dated April 22, 2019, by and between the Registrant and Biocon Limited (Filed With SEC on March 26, 2020)
- Third Amendment to Collaboration and License Agreement, dated December 10, 2019, by and between the Registrant and Biocon Limited (Filed With SEC on March 26, 2020)
- Offer Letter, dated January 19, 2018, by and between the Registrant and Christine Zedelmayer (Filed With SEC on March 26, 2020)
- First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Daniel M. Bradbury (Filed With SEC on March 26, 2020)
- First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Krishna Polu (Filed With SEC on March 26, 2020)
- First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Bruce D. Steel (Filed With SEC on March 26, 2020)
- First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Christine Zedelmayer (Filed With SEC on March 26, 2020)
- Warrant to Purchase Common Stock, dated September 30, 2019, issued to Oxford Valley Finance LLC (Filed With SEC on November 12, 2019)
- Warrant to Purchase Common Stock, dated September 30, 2019, issued to Silicon Valley Bank (Filed With SEC on November 12, 2019)
- Loan and Security Agreement, effective as of September 30, 2019, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 12, 2019)
- Equillium, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 12, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 2, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on October 2, 2018)
- Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on October 2, 2018)
- Equillium, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on October 2, 2018)
- Equillium, Inc. Non-Employee Director Compensation Policy (Filed With SEC on October 2, 2018)
- First Amendment to Collaboration and License Agreement, effective as of September 28, 2018, by and between the Registrant and Biocon Limited (Filed With SEC on October 2, 2018)
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on September 17, 2018)
- Equillium, Inc. 2017 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on September 17, 2018)
- Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on September 17, 2018)
- Equillium, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on September 17, 2018)
- Equillium, Inc. Non-Employee Director Compensation Policy (Filed With SEC on September 17, 2018)
- Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Filed With SEC on September 17, 2018)
- Clinical Supply Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Filed With SEC on September 17, 2018)
- Standard Office Lease, effective as of February 1, 2018, by and between the Registrant and La Jolla Shores Plaza, LLC (Filed With SEC on September 17, 2018)
- Offer Letter, dated June 1, 2018, by and between the Registrant and Daniel M. Bradbury (Filed With SEC on September 17, 2018)
- Offer Letter, dated March 19, 2018, by and between the Registrant and Jason A. Keyes (Filed With SEC on September 17, 2018)
- Offer Letter, dated June 1, 2018, by and between the Registrant and Bruce D. Steel (Filed With SEC on September 17, 2018)
- Amended and Restated Offer Letter, dated June 7, 2018, by and between the Registrant and Stephen Connelly, Ph.D (Filed With SEC on September 17, 2018)
- Offer Letter, dated August 1, 2018, by and between the Registrant and Krishna Polu, M.D (Filed With SEC on September 17, 2018)
